Table 3 Comorbidities as risk factors for hospitalization.
From: Course of disease and risk factors for hospitalization in outpatients with a SARS-CoV-2 infection
Risk factor | Individuals with this risk factor* | Univariate analyses | Multivariate analyses*** | ||
|---|---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | ||
Age ≥ 60 | 329 (39.5%) | 5.66 (3.93–8.15) | < 10–20 | 3.52 (2.02–6.20) | 1.3 × 10–5 |
Male sex | 365 (43.6%) | 2.31 (1.65–3.24) | 8.0 × 10–7 | ||
Cardiovascular diseases | 132 (15.9%) | 4.70 (3.16–6.99) | 6.5 × 10–16 | 1.84 (1.05–3.23) | 0.03 |
Hypertension | 345 (41.4%) | 2.47 (1.75–3.46) | 1.3 × 10–7 | ||
Peripheral artery disease | 17 (2.0%) | 4.47 (1.70–11.8) | 0.001 | ||
Diabetes mellitus | 94 (11.3%) | 4.54 (2.90–7.10) | 1.6 × 10–12 | 2.41 (1.32–4.39) | 0.004 |
Pulmonary disease | 97 (11.6%) | 2.68 (1.71–4.20) | 1.0 × 10–5 | ||
COPD | 20 (2.4%) | 23.1 (6.69–79.7) | 1.8 × 10–12 | 5.95 (1.36–26.2) | 0.02 |
Asthma | 38 (4.5%) | 0.55 (0.21–1.43) | ns | ||
Neurological disease | 88 (10.6%) | 5.81 (3.66–9.21) | 4.5 × 10–16 | 3.22 (1.70–6.09) | 3.4 × 10–4 |
Stroke | 27 (3.3%) | 6.16 (2.80–13.54) | 3.5 × 10–7 | ||
Neurological disease and stroke | 69 (8.3%) | 5.49 (3.30–9.14) | 8.7 × 10–13 | ||
Neurological disease other than stroke | 61 (7.2%) | 4.71 (2.76–8.04) | 9.2 × 10–10 | ||
Kidney diseases | 59 (7.1%) | 5.00 (2.90–8.59) | 3.1 × 10–10 | 2.48 (1.19–5.15) | 0.02 |
Disability** | 137 (19.7%) | 3.56 (1.79–7.07) | 1.3 × 10–4 | ||
ACE or AT1 inhibitors | 264 (50.5%) | 2.23 (1.46–3.41) | 1.8 × 10–4 | ||
ACE inhibitors | 133 (25.4%) | 1.78 (1.14–2.78) | 0.01 | ||
AT1 antagonists | 133 (25.4%) | 1.53 (0.97–2.39) | ns | ||
